In particular, ILT3 high expression on a specific subset of G-MDSCs, defined as CD11b+CD14−HLA-DR−CD33+CD15+ILT3high, was correlated with reduced survival into NSCLC patients (246). This evidence concerns the gene ITGAM and non-small cell lung carcinoma.